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Abstract
Background: Organ dysfunction is common after cardiac arrest and associated with worse short-term outcome,
but its impact on long-term outcome and treatment costs is unknown.
Methods: We used nationwide registry data from the intensive care units (ICU) of the five Finnish university
hospitals to evaluate the association of 24-h extracerebral Sequential Organ Failure Assessment (24h-EC-SOFA) score
with 1-year survival and healthcare-associated costs after cardiac arrest. We included adult cardiac arrest patients
treated in the participating ICUs between January 1, 2003, and December 31, 2013. We acquired the confirmed
date of death from the Finnish Population Register Centre database and gross 1-year healthcare-associated costs
from the hospital billing records and the database of the Finnish Social Insurance Institution.
Results: A total of 5814 patients were included in the study, and 2401 were alive 1 year after cardiac arrest. Median
(interquartile range (IQR)) 24h-EC-SOFA score was 6 (5–8) in 1-year survivors and 7 (5–10) in non-survivors. In
multivariate regression analysis, adjusting for age and prior independency in self-care, the 24h-EC-SOFA score had
an odds ratio (OR) of 1.16 (95% confidence interval (CI) 1.14–1.18) per point for 1-year mortality.
Median (IQR) healthcare-associated costs in the year after cardiac arrest were €47,000 (€28,000–75,000) in 1-year
survivors and €12,000 (€6600–25,000) in non-survivors. In a multivariate linear regression model adjusting for age
and prior independency in self-care, an increase of one point in the 24h-EC-SOFA score was associated with an
increase of €170 (95% CI €150–190) in the cost per day alive in the year after cardiac arrest. In the same model, an
increase of one point in the 24h-EC-SOFA score was associated with an increase of €4400 (95% CI €3300–5500) in
the total healthcare-associated costs in 1-year survivors.
Conclusions: Extracerebral organ dysfunction is associated with long-term outcome and gross healthcare-
associated costs of ICU-treated cardiac arrest patients. It should be considered when assessing interventions to
improve outcomes and optimize the use of resources in these patients.
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Background
Cardiac arrest is an extensively studied topic due to its
devastating consequences [1]. Cardiac arrest may itself
cause end-organ damage leading to life-threatening
organ dysfunction despite successful return of spontan-
eous circulation (ROSC) [2]. In addition to this the sys-
temic inflammatory response which follows (often called
“post cardiac arrest syndrome”) is characterized by a
sepsis-like inflammatory response which may precipitate
multiple organ failure (MOF) and death [3, 4]. Contem-
porary treatment of cardiac arrest patients in the ICU is
focused on supporting the recovery of the central nervous
system and the myocardium after ischaemia. The dysfunc-
tion of other organ systems after cardiac arrest may have
an impact on recovery but has received less attention.
The Sequential (or sepsis-related) Organ Failure As-
sessment (SOFA) score is widely used for estimating the
severity of MOF. The SOFA score was originally devel-
oped for the evaluation of organ failure in sepsis [5], but
it has later been validated as a general scoring system
for all critically ill patients [6–11].
The extracerebral (EC-)SOFA score [i.e. SOFA score
excluding the central nervous system (CNS) sub-score]
can be used to evaluate the degree of MOF outside the
central nervous system. Two previous single-centre
studies have shown an association of EC-SOFA with
in-hospital and 28-day mortality in cardiac arrest pa-
tients [12, 13], and one multi-centre study found an as-
sociation of admission renal SOFA sub-score with ICU
mortality [14].
The aim of this study was to quantify the impact of
early extracerebral organ failure, measured as the
EC-SOFA score at 24 h (24h-EC-SOFA), on 1-year sur-
vival and healthcare-associated costs in cardiac arrest
patients treated in the ICU.
Methods
Study population
This is a retrospective study conducted at the five uni-
versity hospitals of Finland. These five centres serve a
population of 3.2 million covering 60% of the entire
population of Finland. We included adult cardiac arrest
patients treated in the participating ICUs between Janu-
ary 1, 2003, and December 31, 2013. The year 2003 was
chosen as the starting point because it was the first year
when therapeutic hypothermia became widely used in
the treatment of cardiac arrest patients in the participat-
ing centres [15]. Only the first event of cardiac arrest
was considered. Cardiac arrest was recognized as admis-
sion diagnosis of cardiac arrest according to Acute
Physiology and Chronic Health Evaluation III (APACHE
III) or positive value for Therapeutic Intervention Scor-
ing System 76 (TISS-76) item of “cardiac arrest and/or
countershock within past 48 h”. Complete data for
admission date and day of death/vital status at the end
of 1-year follow-up was required for inclusion. Patients
with missing SOFA score were excluded.
Database
The Finnish social security and healthcare system is
government-based. Each Finnish resident is assigned a
unique personal identification code which is used to
identify the person in medical records, social security re-
cords, and national registers. We used this identification
code to combine data from different sources.
Medical data were extracted from the Finnish Intensive
Care Consortium (FICC) database [16]. These included
the SOFA score and the premorbid physical status as a
simplified World Health Organization-Eastern Coopera-
tive Oncology Group (WHO/ECOG) classification [17],
where “independent” was defined as the patient being in-
dependent in self-care and “dependent” was defined as the
patient being partly or fully dependent on help in self-care
prior to hospital admission. We linked these data with the
confirmed date of death obtained from the Finnish Popu-
lation Register Centre database, which records all deaths
of Finnish residents.
Furthermore, we linked data on gross 1-year
healthcare-associated costs from the hospital billing re-
cords, rehabilitation costs and social security costs ob-
tained from the Social Insurance Institution. The
hospital costs include all costs until hospital discharge
(diagnostics, ICU stay, ward stay, operative treatment
etc.). The rehabilitation costs were calculated by multi-
plying the number of days spent in the rehabilitation
unit with the average price per day for units of the cor-
responding level. The Finnish Social Insurance Institu-
tion reimburses disability and sickness allowances,
private physician and physiotherapist expenses, prescrip-
tion drug expenses and medical transportation expenses.
All social insurance reimbursements during the year fol-
lowing hospital admission were included. Effective cost
per survivor (ECPS) was calculated by dividing the sum
of total costs for all patients with the number of survi-
vors [18]. We adjusted all costs to the value of euro in
the year 2013 according to the consumer price index
(CPI) in Finland.
Nested cohort
We performed an additional analysis of a nested cohort
consisting of patients treated in one (Helsinki University
Hospital) of the five centres of the full data. For this co-
hort, additional data were available according to the
Utstein criteria [19, 20] including the delay from collapse
to return of spontaneous circulation (ROSC), type of ini-
tial rhythm during cardiac arrest (shockable or not),
whether the cardiac arrest was witnessed or not, and
1-year cerebral performance category (CPC) [21, 22].
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We defined good neurologic outcome as 1-year CPC 1
or 2 and poor neurologic outcome as 1-year CPC 3 to 5.
Furthermore, the location where cardiac arrest had oc-
curred was recorded, allowing stratification of the nested
cohort data in out-of-hospital cardiac arrest (OHCA)
and in-hospital cardiac arrest (IHCA). Cardiac arrests in
the ICU (ICUCA) were included in the IHCA group in
this study.
Statistics
We performed the statistical analyses with the SPSS soft-
ware (version 24.0, IBM, Armonk, NY, USA). We present
continuous data as medians with interquartile ranges
(IQR) and categorical data as percentages of the whole.
We tested group differences with a chi-square test, Stu-
dent’s t test, Mann-Whitney U test or Kruskal-Wallis test,
as appropriate. We performed Kaplan-Meier analysis to
evaluate the difference in 1-year survival across quartiles
of the 24h-EC-SOFA score. We used logistic regression
models to search for variables that were independently as-
sociated with outcome. For testing the association of the
24h-EC-SOFA score with healthcare-associated costs, we
used linear regression models. To avoid the confounding
effect of early deaths causing low costs, we calculated a
“cost per day alive” variable by dividing the total costs of a
given patient by the number of days the patient remained
alive during the first year after the cardiac arrest. If the pa-
tient was still alive 1 year after the arrest, then the cost per
day alive variable was calculated by dividing the total costs
during the year after cardiac arrest by 365.
STROBE statement
The manuscript was completed according to STROBE
standards [23].
Results
In total, 5814 patients were included in the study, and of
these, 2401 were alive 1 year after the cardiac arrest. Me-
dian (IQR) survival time for 1-year non-survivors was 5
(2–14) days. Patient selection is shown in Fig. 1. Charac-
teristics of the study population are described in Table 1,
and those of the nested cohort in Additional file 1: Table
S1. The values of the 24h-EC-SOFA score were normally
distributed in the groups stratified by outcome, with a
range from 0 to 18 (Additional file 2: Figure S1). The
distribution of the full 24h-SOFA score ranged from 0 to
21 (Additional file 2: Figure S1).
Outcome
In Kaplan-Meier analysis, 1-year survival was signifi-
cantly different between quartiles of 24h-EC-SOFA (log-
rank P < 0.001; Fig. 2). One-year survival had a rising
trend from 38% in 2003 to 47% in 2013 (Additional file 3:
Figure S2). In a logistic regression model adjusting for
age and the premorbid physical status, the 24h-EC-SOFA
score was associated with 1-year mortality [odds ratio (OR)
1.16 and 95% confidence interval (CI) 1.14–1.18; Table 2].
Similarly, the full 24h-SOFA score was associated with
1-year mortality in a logistic regression model adjusting for
age and the premorbid physical status (OR 1.22, 95% CI
1.20–1.24; Additional file 4: Table S2). All sub-scores, ex-
cept the cardiovascular sub-score, were independently asso-
ciated with 1-year mortality when the individual
EC-sub-scores were tested (respiration, OR 1.18, 95% CI
1.12–1.25; coagulation, OR 1.09, 95% CI 1.00–1.18; liver,
OR 1.23, 95% CI 1.10–1.37; renal, OR 1.52, 95% CI 1.44–
1.61; Additional file 5: Table S3). Univariate analysis of the
variables used in the logistic regression models is presented
in Additional file 6: Table S4.
Healthcare-associated costs
The sum of costs recorded in all 5814 patients during the
year following cardiac arrest was €230,000,000. The 1-year
ECPS was €96,000. Median costs in the first year after car-
diac arrest were €47,000 in 1-year survivors and €12,000 in
non-survivors (Table 1). During the study years, ECPS
remained between €85,000 and €110,000 (Additional file 7:
Figure S3). Median costs recorded for 1-year survivors were
lowest in 2003 (€38,000) and highest in 2004 (€52,000), plat-
eauing thereafter (Additional file 8: Figure S4). Median costs
recorded for 1-year non-survivors had a rising trend from
€9900 in 2003 to €16,000 in 2013(Additional file 8: Figure
S4). When the data were divided in quartiles of the
24h-EC-SOFA score, the total costs of 1-year survivors dif-
fered significantly between groups (P < 0.001); higher
24h-EC-SOFA score was associated with higher costs (Fig. 3).
The same was true when the quartiles of the 24h-EC-SOFA
score were tested for the association with cost per day alive
during the first year after cardiac arrest (P < 0.001). The dif-
ferences were similar for quartiles of the 24 h-SOFA score
(P < 0.001 for the difference in total costs in 1-year survivors
and P < 0.001 for the difference in cost per day alive; Fig. 3).
In a linear regression model adjusting for age and premor-
bid physical status, an increase of one point in the
24h-EC-SOFA score was associated with an increase of €170
(95% CI €150–190) in the cost per day alive in the first year
after cardiac arrest (Table 3). When the EC-sub-scores were
tested, renal, cardiovascular, respiratory and coagulation
sub-scores were significantly associated with an increase in
the cost per day alive (increase per one point rise: respiration,
€120, 95% CI €61 - 170; coagulation, €300, 95% CI €230 -
370; cardiovascular, €90, 95% CI €41 - 140; renal, €400, 95%
CI €350 – 440; Additional file 9: Table S5). In 1-year survi-
vors, an increase of one point in the 24h-EC-SOFA score
was associated with an increase of €4400 (95% CI €3300–
5500) in total healthcare-associated costs recorded during
the year following the cardiac arrest (Table 4). When the
EC-sub-scores were tested, renal, respiratory and coagulation
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Fig. 1 Flow chart of patient selection
Table 1 Characteristics of the study population
All
N = 5814 (100%)
One-year survivors
N = 2401 (41%)
One-year non-survivors
N = 3413 (59%)
P value1
Age (years) 65 (56–74) 63 (54–71) 67 (57–76) < 0.01
Gender (male) 71% 72% 69% < 0.01
Physical status (independent)2 84% 92% 79% < 0.01
24h-EC-SOFA 7 (5–9) 6 (5–8) 7 (5–10) < 0.01
24 h-SOFA 9 (7–12) 8 (6–10) 10 (8–13) < 0.01
One-year costs (€1000) 23 (10–50) 47 (28–75) 12 (6.6–25) < 0.01
Cost per day alive (€) 880 (150–2500) 130 (77–200) 2200 (1300–3400) < 0.01
1P value for comparison between outcome groups
2Simplified WHO/ECOG-classification before cardiac arrest
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sub-scores were significantly associated with an increase of
total healthcare-associated costs recorded during the year
following the cardiac arrest (increase per one point rise: res-
piration, €7300, 95% CI €4800 - 9800; coagulation, €4600,
95% CI €1000 - 8300; renal, €7900, 95% CI €5000 - 11,000;
Additional file 10: Table S6).
Outcome in the nested cohort
For the nested cohort, the logistic regression model was
complemented with variables describing conditions dur-
ing resuscitation: whether the initial cardiac rhythm dur-
ing cardiac arrest was shockable, the delay from collapse
to ROSC and whether the cardiac arrest was witnessed.
In this model, the 24h-EC-SOFA score was associated
with 1-year mortality (OR 1.19, 95% CI 1.12–1.25 per
point of 24h-EC-SOFA) and poor neurologic outcome
(OR 1.15, 95% CI 1.09–1.21 per point of 24h-EC-SOFA;
Table 2). When the individual EC-sub-scores were
tested, respiratory and renal sub-scores were independ-
ently associated with both 1-year mortality (respiration,
OR 1.16, 95% CI 1.02–1.32; renal, OR 1.50, 95% CI
1.32–1.70) and poor neurologic outcome (respiration,
OR 1.17, 95% CI 1.02–1.33; renal, OR 1.42, 95% CI
1.25–1.63; Additional file 11: Table S7). The association
of the 24h-EC-SOFA score with 1-year mortality and poor
neurologic outcome remained significant in subgroup ana-
lysis of both OHCA (1-year mortality OR 1.20, 95% CI
1.10–1.31 per point of 24h-EC-SOFA; poor neurologic
outcome OR 1.15, 95% CI 1.05–1.25 per point of
24h-EC-SOFA) and IHCA patients (1-year mortality OR
1.15, 95% CI 1.06–1.24 per point of 24h-EC-SOFA; poor
neurologic outcome OR 1.11, 95% CI 1.03–1.21 per point
of 24h-EC-SOFA; Additional file 12: Table S8).
Healthcare-associated costs in the nested cohort
In the nested cohort, the total costs documented for
the 1324 patients was €65,000,000 and 1-year ECPS
was €94,000. The cohort included 772 OHCA and
552 IHCA patients. Median (IQR) survival time for
1-year non-survivors was 5 (3–10) days in OHCA
and 8 (3–20) days in IHCA. In the nested cohort,
the linear regression model adjusting for age and
premorbid physical status indicated an association
of an increase of one point in the 24h-EC-SOFA
score with a €280 (95% CI €230–330) increase in
the cost per day alive. For 1-year survivors, the in-
crease in the total healthcare-associated costs in the
year after cardiac arrest was €7700 (95% CI €5700–
9700) per one-point rise in the 24h-EC-SOFA score.
When the model was complemented with Utstein
Fig. 2 Kaplan-Meier curves for survival up to 1 year after cardiac
arrest in quartiles of the EC-SOFA score. Q1 quartile 1, EC-SOFA
score 0–4; Q2, 5–6; Q3, 7–8; Q4, 9–18. Logrank P value for equality of
survival distributions across quartiles of EC-SOFA
Table 2 Logistic regression model of the association of the 24h-EC-SOFA score with 1-year outcome
Full data Nested cohort
One-year mortality One-year mortality Poor neurologic outcome1
OR 95% CI P OR 95% CI P OR 95% CI P
Age (year) 1.02 1.01 - 1.02 < 0.01 1.03 1.02 - 1.04 < 0.01 1.03 1.02 - 1.04 < 0.01
Physical status (dependent)2 2.60 2.18 - 3.09 < 0.01 2.76 1.60 - 4.74 < 0.01 3.72 2.01 - 6.88 < 0.01
Not shockable3 3.55 2.61 - 4.82 < 0.01 3.89 2.82 - 5.37 < 0.01
ROSC delay (min)4 1.05 1.03 - 1.06 < 0.01 1.05 1.03 - 1.06 < 0.01
Not witnessed5 1.87 1.19 - 2.93 < 0.01 2.05 1.26 - 3.32 < 0.01
24h-EC-SOFA (point) 1.16 1.14 - 1.18 < 0.01 1.19 1.12 - 1.25 < 0.01 1.15 1.09 - 1.21 < 0.01
1Cerebral performance category (CPC) 3–5 1 year after cardiac arrest
2Simplified WHO/ECOG-classification before cardiac arrest
3Not shockable, initial cardiac rhythm during resuscitation not shockable (asystole/pulseless electrical activity)
4ROSC delay, time from collapse to return of spontaneous circulation
5Not witnessed, collapse not witnessed
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variables, the increase in the cost per day alive was
€210 (95% CI €170–260) per 24h-EC-SOFA point.
In 1-year survivors, total healthcare-associated costs
increased €7200 (95% CI €5000–9400) per each add-
itional 24h-EC-SOFA point (Tables 3 and 4). When
the data were stratified according to cardiac arrest
location, the increase in the cost per day alive in
OHCA was €210 (95% CI €150–280) and in IHCA
€200 (95% CI €120–270) per 24h-EC-SOFA point.
In OHCA patients, the total healthcare-associated
costs in 1-year survivors increased €2500 (95% CI
€200–4800) and in IHCA patients €11,000 (95% CI
Fig. 3 Healthcare-associated costs recorded during the first year after cardiac arrest in quartiles of 24h-EC-SOFA and 24h-SOFA scores. Upper
panels: Total healthcare-associated costs in 1-year survivors in quartiles of 24h-EC-SOFA score (left) and full 24h-SOFA score including CNS sub-
score (right). Lower panels: healthcare-associated costs per day alive in quartiles of the 24h-EC-SOFA score (left) and full 24h-SOFA score including
CNS sub-score (right). The cost per day alive was calculated by dividing the total cost by the number of days from cardiac arrest to death. For 1-
year survivors, the cost per day alive was calculated by dividing the total cost by 365 days. Median values (bars) with interquartile range (whiskers)
are presented. ***P < 0.001 for the difference between the four groups (Kruskal-Wallis test)
Table 3 Linear model of the association of the 24h-EC-SOFA score with 1-year healthcare-associated costs per day alive
Cost per day alive (€)
Full data Nested cohort
B 95% CI P B 95% CI P
Age (year) − 3.8 − 8.4 - 0.80 NS 3.8 − 5.1 - 13 NS
Physical status (dependent)1 110 − 67 - 284 NS 220 − 240 - 680 NS
Not shockable2 780 510 - 1,100 < 0.01
ROSC (min)3 37 25 - 49 < 0.01
Not witnessed4 200 − 200 - 610 NS
24h-EC-SOFA (point) 170 150 - 190 < 0.01 210 170 - 260 < 0.01
NS not statistically significant (P > 0.05)
1Simplified WHO/ECOG-classification before cardiac arrest
2Not shockable, initial cardiac rhythm during resuscitation not shockable (asystole/pulseless electrical activity)
3ROSC delay, time from collapse to return of spontaneous circulation
4Not witnessed, collapse not witnessed
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€5600–16,000) per each additional 24h-EC-SOFA
point (Additional files 13 and 14: Tables S9 and
S10).
Discussion
In this large multi-centre cohort, we show that extracer-
ebral organ failure is an important contributor to both
long-term outcome and increased healthcare-associated
costs in cardiac arrest patients. Importantly, we mea-
sured extracerebral organ failure with a simple method,
the 24h-EC-SOFA, and were able to quantify its associ-
ation with long-term resource use in cardiac arrest
survivors.
Outcome and SOFA
Previous studies have shown an association of admission
SOFA and EC-SOFA with 28-/30-day mortality in
single-centre settings of OHCA patients [13, 24, 25].
Association with neurologic outcome has produced con-
flicting results [24, 25]. In a single-centre material in-
cluding both OHCA and IHCA patients, the highest
EC-SOFA score during the first 72 h of ICU stay was as-
sociated with in-hospital mortality and cardiovascular
and respiratory sub-scores were independently predictive
of in-hospital mortality [12]. In a multi-centre database
study including both OHCA and IHCA patients, ICU
non-survivors had higher cardiovascular, respiratory and
renal SOFA sub-scores upon ICU admission but only
renal sub-score was independently associated with
ICU-mortality [14].
To the best of our knowledge, our current study is the
largest study on the association of EC-SOFA with cardiac
arrest patient outcome published to date. In our
multi-centre setting with a mixed cohort of OHCA and
ICHA patients, the association of EC-SOFA with 1-year
outcome was clear. In contrast to other sub-scores, the
cardiovascular sub-score was not independently associated
with the outcome in our cohort, since almost three quar-
ters of patients had 24-h cardiovascular sub-score of 3 or
4, regardless of the outcome group. In line with previous
studies, respiratory and renal sub-scores had a clear asso-
ciation with the outcome in our study population.
It is important to notice that the large overlap between
the outcome groups does not allow the use of
24h-EC-SOFA for predicting outcome on a single patient
level. However, our results emphasize the importance of
the evolving multiple organ failure for long-term mor-
bidity, mortality and healthcare resource use in cardiac
arrest patients on population level. This association
could justify the use of SOFA or EC-SOFA score as an
end-point in small randomized controlled trials on car-
diac arrest in the future instead of mortality, for which
the studies often prove underpowered.
Healthcare-associated costs
Recently, there has been a growing interest in the obvi-
ous socioeconomic burden of cardiac arrest [26]. One of
the first studies assessing the healthcare resource use in
cardiac arrest reported combined pre- and in-hospital
costs for OHCA 6-month survivors to be €36,000
(expressed as 2013 euros) [27]. More recent studies have
reported in-hospital costs of €50,000–60,000 in 2013
euros for patients surviving to hospital discharge after
OHCA or IHCA [28–30]. One previous study reported
OHCA survivors to have combined pre-, in- and
post-hospital healthcare-associated costs of €37,000 in
2013 euros in a 6-month follow-up [31]. In a recent
study of single-centre data published by our group, com-
bined in- and post-hospital healthcare costs in 1-year
follow-up were €59,000 for OHCA and €84,000 for
IHCA hospital survivors in 2013 euros [18].
In our current study, the association of 24h-EC-SOFA
with healthcare-associated costs was clear. Most of the
Table 4 Linear model of the association of the 24h-EC-SOFA score with 1-year total healthcare-associated costs (per €1000) in 1-year
survivors
Total costs in 1-year survivors (€1000)
Full data Nested cohort
B 95% CI P B 95% CI P
Age (year) − 0.85 − 1.1 - -0.64 < 0.01 − 0.48 − 0.85 - –0.10 0.01
Physical status (dependent)1 15 5.1 - 25 < 0.01 28 2.4 - 54 0.03
Not shockable2 15 3.2 - 27 0.01
ROSC (min)3 0.047 − 0.45 - 0.55 NS
Not witnessed4 − 20 − 39 - -0.91 0.04
24h-EC-SOFA (point) 4.4 3.3 - 5.5 < 0.01 7.2 5.0 - 9.4 < 0.01
NS not statistically significant (P > 0.05)
1Simplified WHO/ECOG-classification before cardiac arrest
2Not shockable, initial cardiac rhythm during resuscitation not shockable (asystole/pulseless electrical activity)
3ROSC delay, time from collapse to return of spontaneous circulation
4Not witnessed, collapse not witnessed
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sub-scores (renal and respiratory sub-scores in particular)
had also independent association with costs. This suggests
that early organ failure after cardiac arrest leads to both
short- and long-term morbidity reflected as increased in-
and post-hospital expenses.
The analysis of our nested cohort clearly shows
that the association of organ failure with outcome
and costs is not redundant to more detailed infor-
mation considering the conditions during and after
cardiac arrest and resuscitation. The similarity of
the ECPS values of the nested cohort and the full
data (€94,000 and €96,000, respectively) suggest that
the case-mix in the nested cohort was not markedly
different from that of the full data.
Strengths and limitations of the study
This study has a number of strengths. It is a large multi-
centre study conducted in a country of government-
funded social security and healthcare systems. The
follow-up time of 1 year is long enough to reliably dissect
long-term survivors from non-survivors. We have
exploited the unique possibility provided by the nature of
the government-funded system to combine data from dif-
ferent registries to acquire information on long-term sur-
vival and gross healthcare-associated costs from different
healthcare providers. Naturally, there are also limitations.
Our data are limited to one country—the generalizability
to other healthcare systems is not certain. The study is
retrospective, and the data were gathered during a period
of 11 years. The treatment of cardiac arrest patients has
evolved during the data gathering period and the 4-year
delay from the end of follow-up to the publication of the
study. Unfortunately, distinction between OHCA and
IHCA, which have largely different aetiology, was not pos-
sible in the main cohort. Furthermore, the FICC database
provided only a point measure of SOFA score as the worst
values recorded during the first 24 h, not allowing for
evaluation of the temporal change in SOFA score.
Conclusions
We conclude that extracerebral organ failure, mea-
sured as the 24h-EC-SOFA score, is associated with
long-term outcome and gross healthcare-associated
costs of ICU-treated cardiac arrest patients. These as-
sociations encourage future research on the potential
of EC-SOFA or SOFA score as end points in random-
ized controlled trials on cardiac arrest. From the clin-
ical point of view, our data remind us that the full
spectrum of multiple organ failure must be consid-
ered in the pursuit to reduce morbidity, increase sur-
vival, and optimize the use of healthcare resources
after cardiac arrest.
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